subject
hicn
medical
news
part
cut
volume
number
april
health
infocom
network
medical
newsletter
editor
david
dodell
dmd
north
nd
street
suite
scottsdale
arizona
usa
telephone
fax
compilation
copyright
david
dodell
dmd
rights
reserved
license
hereby
granted
republish
electronic
media
fees
charged
long
text
copyright
notice
license
attached
intact
republished
portion
portions
health
infocom
network
newsletter
distributed
biweekly
articles
medical
nature
welcomed
article
please
contact
editor
information
submit
interested
joining
automated
distribution
system
please
contact
editor
email
address
editor
internet
fidonet
bitnet
listserv
internet
anonymous
ftp
vmnodakedu
notification
list
fax
delivery
contact
editor
information
b
l
e
f
c
n
e
n
centers
disease
control
prevention
mmwr
april
rates
cesarean
delivery
malaria
among
us
embassy
personnel
fda
approval
hib
vaccine
childreninfants
dental
news
workshop
explores
oral
manifestations
hiv
infection
food
drug
administration
news
fda
approves
depo
provera
injectable
contraceptive
new
rules
speed
approval
drugs
lifethreatening
illnesses
articles
research
promises
preventingslowing
blindness
retinal
disease
affluent
diet
increases
risk
heart
disease
general
announcments
publications
health
professionals
national
cancer
institute
publications
patients
available
national
cancer
institute
aids
news
summaries
aids
daily
summary
april
april
aids
statistics
worldwide
aids
statistics
hicnet
medical
newsletter
page
volume
number
april
centers
disease
control
prevention
mmwr
rates
cesarean
delivery
united
states
source
mmwr
date
apr
cesarean
deliveries
accounted
nearly
million
approximately
million
annual
deliveries
united
states
since
table
cesarean
rate
united
states
third
highest
among
reporting
countries
exceeded
brazil
puerto
rico
report
presents
data
cesarean
deliveries
cdcs
national
hospital
discharge
survey
nhds
compares
data
previous
years
data
discharges
shortstay
nonfederal
hospitals
collected
annually
since
nhds
conducted
cdcs
national
center
health
statistics
medical
demographic
information
abstracted
sample
inpatients
discharged
participating
hospitals
cesareans
vaginal
births
prior
cesarean
vbac
presented
report
based
weighted
national
estimates
nhds
sample
approximately
women
discharged
delivery
estimated
numbers
live
births
type
delivery
calculated
applying
cesarean
rates
nhds
live
births
national
vital
registration
data
therefore
estimates
number
cesareans
report
agree
previously
published
data
based
solely
nhds
stated
differences
analysis
significant
confidence
level
based
twotailed
ttest
critical
value
cesareans
per
deliveries
rate
similar
rates
table
primary
cesarean
rate
ie
number
first
cesareans
per
deliveries
women
previous
cesareans
also
stable
ranging
cesarean
rate
south
significantly
p
higher
rates
west
midwest
northeast
rates
higher
mothers
aged
greater
equal
years
younger
women
proprietary
hospitals
nonprofit
government
hospitals
hospitals
fewer
beds
larger
hospitals
deliveries
blue
crossblue
shield
private
insurance
expected
source
payment
sources
payment
table
pattern
characterized
primary
cesarean
deliveries
since
early
number
percentage
births
older
women
increased
however
age
distribution
mothers
remained
overall
cesarean
rate
would
essentially
observed
based
nhds
approximately
live
births
hicnet
medical
newsletter
page
volume
number
april
estimated
cesarean
delivery
estimated
births
repeat
cesareans
primary
cesareans
since
approximately
primary
cesareans
performed
annually
women
previous
cesarean
delivered
vaginally
compared
cesareans
associated
previous
cesarean
dystocia
ie
failure
labor
progress
breech
presentation
fetal
distress
specified
complications
average
hospital
stay
deliveries
days
comparison
hospital
stay
primary
cesarean
delivery
days
repeat
cesarean
days
nearly
twice
duration
vbac
deliveries
days
vaginal
deliveries
vbacs
days
average
hospital
stay
deliveries
days
primary
cesareans
days
repeat
cesareans
days
vbac
nonvbac
vaginal
deliveries
days
respectively
reported
office
vital
health
statistics
systems
national
center
health
statistics
cdc
editorial
note
cesarean
rate
united
states
steadily
increased
however
findings
report
indicate
rates
stable
since
little
evidence
maternal
child
health
status
improved
time
cesareans
associated
increased
risk
complications
childbirth
national
health
objective
year
reduce
overall
cesarean
rate
fewer
per
deliveries
primary
cesarean
rate
fewer
per
deliveries
objective
postpartum
complications
including
urinary
tract
wound
infections
may
account
part
longer
hospital
stays
cesarean
deliveries
vaginal
births
moreover
prolonged
hospital
stays
cesarean
deliveries
substantially
increase
healthcare
costs
example
average
costs
cesarean
vaginal
deliveries
respectively
additional
cost
cesarean
delivery
includes
physician
fees
hospital
charges
cesarean
rate
year
objective
instead
number
cesarean
births
would
decreased
versus
resulting
savings
billion
physician
fees
hospital
charges
despite
steady
increase
vbac
rates
since
several
factors
may
impede
progress
toward
year
national
health
objectives
cesarean
delivery
example
vbac
rates
substantially
reflect
number
women
offered
trial
labor
increasingly
encouraged
since
women
offered
trial
labor
could
deliver
vaginally
level
already
achieved
many
hospitals
trial
labor
routinely
offered
hospitals
surveyed
recent
year
hicnet
medical
newsletter
page
volume
number
april
national
data
available
vbac
rate
according
nhds
data
year
objective
specifies
vbac
rate
based
women
prior
cesarean
regardless
whether
trial
labor
attempted
reach
overall
cesarean
rate
goal
however
increases
vbac
rate
need
combined
substantial
reduction
primary
rate
one
hospital
succeeded
reducing
rate
cesarean
delivery
applying
objective
criteria
four
common
indications
cesarean
delivery
requiring
second
opinion
instituting
peerreview
process
recommendations
decreasing
cesarean
delivery
rates
include
eliminating
incentives
physicians
hospitals
equalizing
reimbursement
vaginal
cesarean
deliveries
public
dissemination
physician
hospitalspecific
cesarean
delivery
rates
increase
public
awareness
differences
practices
addressing
malpractice
concerns
may
important
factor
maintaining
high
rates
cesarean
delivery
references
notzon
fc
international
differences
use
obstetric
interventions
jama
graves
ej
nchs
summary
national
hospital
discharge
survey
hyattsville
maryland
us
department
health
human
services
public
health
service
cdc
advance
data
taffel
sm
placek
pj
kosary
cl
us
cesarean
section
rates
update
birth
public
health
service
healthy
people
national
health
promotion
disease
prevention
objectives
full
report
commentary
washington
dc
us
department
health
human
services
public
health
service
dhhs
publication
phs
danforth
dn
cesarean
section
jama
hospital
insurance
association
america
table
cost
maternity
care
physicians
fees
hospital
charges
census
region
based
consumer
price
index
source
book
health
insurance
data
washington
dc
hospital
insurance
association
america
committee
obstetrics
acog
committee
opinion
guidelines
vaginal
delivery
previous
cesarean
birth
washington
dc
american
college
obstetricians
gynecologists
hicnet
medical
newsletter
page
volume
number
april
rosen
mg
dickinson
jc
vaginal
birth
cesarean
metaanalysis
indicators
success
obstet
gynecol
shiono
ph
fielden
jg
mcnellis
rhoads
gg
pearse
wh
recent
trends
cesarean
birth
trial
labor
rates
united
states
jama
myers
sa
gleicher
n
successful
program
lower
cesareansection
rates
n
engl
j
med
use
trade
names
commercial
sources
identification
imply
endorsement
public
health
service
us
department
health
human
services
hicnet
medical
newsletter
page
volume
number
april
malaria
among
us
embassy
personnel
kampala
uganda
source
mmwr
date
apr
treatment
prevention
malaria
africa
become
challenging
complex
problem
increasing
drug
resistance
although
risk
acquiring
malaria
us
citizens
dependents
stationed
overseas
generally
low
risk
varies
substantially
unpredictably
may
office
medical
services
department
state
omsdos
cdc
notified
increased
number
malaria
cases
among
official
us
personnel
stationed
kampala
uganda
review
health
records
embassy
health
unit
ehu
kampala
indicated
cases
malaria
diagnosed
official
personnel
march
june
compared
two
cases
period
ehu
omsdos
cdc
conducted
investigation
confirm
reported
malaria
cases
identify
potential
risk
factors
malaria
among
us
embassy
personnel
report
summarizes
results
investigation
malaria
blood
smears
reported
casepatients
available
review
omsdos
cdc
case
malaria
confirmed
slide
positive
plasmodium
sp
persons
slide
confirmed
malaria
questionnaire
distributed
persons
served
ehu
obtain
information
residence
activities
use
malaria
chemoprophylaxis
use
personal
protection
measures
ie
using
bednets
insect
repellents
window
door
screens
wearing
long
sleeves
pants
evening
persons
eligible
survey
responded
risk
malaria
associated
sex
location
residence
kampala
although
risk
malaria
higher
among
children
aged
less
equal
years
among
persons
greater
years
difference
significant
relative
risk
rr
confidence
interval
ci
eightytwo
percent
cases
occurred
among
persons
living
kampala
years
compared
living
less
year
travel
outside
kampala
area
rural
settings
associated
increased
risk
malaria
four
malaria
chemoprophylaxis
regimens
used
persons
participated
survey
mefloquine
chloroquine
proguanil
chloroquine
alone
proguanil
alone
addition
persons
responded
using
malaria
chemoprophylaxis
risk
malaria
significantly
lower
among
persons
using
either
mefloquine
chloroquine
proguanil
among
persons
using
regimens
prophylaxis
rr
ci
twelve
persons
using
prophylaxis
reported
side
effects
fear
possible
side
effects
reason
risk
malaria
lower
among
persons
reported
using
bednets
hicnet
medical
newsletter
page
volume
number
april
time
among
persons
sometimes
rarely
used
bednets
rr
ci
risk
malaria
also
lower
among
persons
consistently
used
insect
repellent
evening
compared
rarely
used
repellent
rr
upper
confidence
limit
risk
malaria
associated
failure
window
door
screens
wear
long
sleeves
pants
evening
result
investigation
ehu
staff
reviewed
personnel
need
use
comply
recommended
malaria
chemoprophylaxis
regimens
ehu
staff
also
emphasized
need
use
personal
protection
measures
made
plans
obtain
insecticideimpregnated
bednets
provide
window
door
screens
personnel
reported
us
embassy
health
unit
kampala
uganda
office
medical
svcs
dept
state
washington
dc
malaria
br
div
parasitic
diseases
national
center
infectious
diseases
cdc
editorial
note
uganda
increase
malaria
among
us
personnel
attributed
poor
adherence
recommended
malaria
chemoprophylaxis
regimens
use
personal
protection
measures
period
increased
malaria
transmission
intensified
chloroquine
resistance
subsaharan
africa
findings
report
underscore
need
provide
initial
continued
counseling
regarding
malaria
prevention
persons
living
abroad
malariaendemic
areas
preventive
measures
also
important
shortterm
travelers
areas
mefloquine
effective
prophylaxis
regimen
africa
areas
chloroquineresistant
p
falciparum
however
areas
eg
thailand
resistance
mefloquine
may
limit
effectiveness
africa
efficacy
mefloquine
compared
chloroquine
alone
preventing
infection
p
falciparum
mefloquine
safe
well
tolerated
given
mg
per
week
year
period
risk
serious
adverse
reactions
possibly
associated
mefloquine
prophylaxis
eg
psychosis
convulsions
low
ie
episodes
per
users
risk
less
severe
adverse
reactions
eg
dizziness
gastrointestinal
complaints
sleep
disturbances
similar
antimalarial
chemoprophylactics
doxycycline
similar
prophylactic
efficacy
mefloquine
need
daily
dosing
may
reduce
compliance
effectiveness
regimen
chloroquine
alone
effective
prophylaxis
areas
intense
chloroquine
resistance
eg
southeast
asia
africa
africa
persons
take
mefloquine
doxycycline
chloroquine
proguanil
alternative
although
less
effective
regimen
chloroquine
used
malaria
prevention
areas
chloroquineresistant
p
falciparum
reported
countryspecific
recommendations
preventing
malaria
information
hicnet
medical
newsletter
page
volume
number
april
dosage
precautions
malaria
chemoprophylaxis
regimens
available
health
information
international
travel
ie
yellow
book
hours
day
telephone
fax
references
lobel
ho
miani
eng
et
al
longterm
malaria
prophylaxis
weekly
mefloquine
peace
corps
volunteers
effective
well
tolerated
regimen
lancet
world
health
organization
review
central
nervous
system
adverse
events
related
antimalarial
drug
mefloquine
geneva
world
health
organization
publication
whomal
pang
l
limsomwong
n
singharaj
p
prophylactic
treatment
vivax
falciparum
malaria
lowdose
doxycycline
j
infect
dis
pang
l
limsomwong
n
boudreau
ef
singharaj
p
doxycycline
prophylaxis
falciparum
malaria
lancet
cdc
health
information
international
travel
atlanta
us
department
health
human
services
public
health
service
dhhs
publication
cdc
hicnet
medical
newsletter
page
volume
number
april
fda
approval
use
new
haemophilus
b
conjugate
vaccine
combined
diphtheriatetanuspertussis
haemophilus
b
conjugate
vaccine
infants
children
source
mmwr
date
apr
haemophilus
influenzae
type
b
hib
conjugate
vaccines
recommended
use
infants
since
routine
use
infant
vaccination
contributed
substantial
decline
incidence
hib
disease
united
states
vaccines
diphtheria
tetanus
pertussis
infancy
childhood
administered
routinely
united
states
since
late
associated
greater
reduction
morbidity
mortality
associated
infection
organisms
increasing
number
vaccines
routinely
recommended
infants
high
priority
development
combined
vaccines
allow
simultaneous
administration
fewer
separate
injections
food
drug
administration
fda
recently
licensed
two
new
products
vaccinating
children
diseases
haemophilus
b
conjugate
vaccine
tetanus
toxoid
conjugate
acthib
trademark
vaccination
hib
disease
combined
diphtheria
tetanus
toxoids
wholecell
pertussis
vaccine
dtp
hib
conjugate
vaccine
tetramune
trademark
combination
vaccines
formulated
use
vaccinating
children
diphtheria
tetanus
pertussis
hib
disease
acthib
trademark
march
fda
approved
new
haemophilus
b
conjugate
vaccine
polyribosylribitol
phosphatetetanus
toxoid
conjugate
prpt
manufactured
pasteur
merieux
serum
et
vaccins
distributed
acthib
trademark
connaught
laboratories
inc
swiftwater
pennsylvania
vaccine
licensed
use
infants
threedose
primary
vaccination
series
administered
ages
months
previously
unvaccinated
infants
months
age
receive
two
doses
months
apart
previously
unvaccinated
children
months
age
receive
one
dose
booster
dose
administered
months
age
recommended
children
previously
unvaccinated
children
months
age
receive
single
dose
require
booster
infants
receiving
primary
vaccination
series
acthib
trademark
consecutive
doses
months
age
develop
geometric
mean
titer
antihaemophilus
b
polysaccharide
antibody
greater
ugml
response
similar
infants
receive
recommended
series
previously
licensed
haemophilus
b
conjugate
vaccines
efficacy
demonstrated
prospective
trials
two
us
efficacy
trials
prpt
terminated
early
concomitant
licensure
haemophilus
b
conjugate
vaccines
hicnet
medical
newsletter
page
volume
number
april
use
infants
studies
cases
invasive
hib
disease
detected
approximately
infants
vaccinated
prpt
studies
suggest
efficacy
prpt
vaccine
similar
licensed
hib
vaccines
tetramune
trademark
march
fda
approved
combined
diphtheria
tetanus
toxoids
wholecell
pertussis
vaccine
dtp
haemophilus
b
conjugate
vaccine
tetramune
trademark
available
lederlepraxis
biologicals
pearl
river
new
york
combines
two
previously
licensed
products
dtp
triimmunol
registered
manufactured
lederle
laboratories
pearl
river
new
york
haemophilus
b
conjugate
vaccine
hibtiter
registered
manufactured
praxis
biologics
inc
rochester
new
york
vaccine
licensed
use
children
aged
months
years
protection
diphtheria
tetanus
pertussis
hib
disease
indications
vaccination
dtp
vaccine
haemophilus
b
conjugate
vaccine
coincide
based
demonstration
co
mparable
higher
antibody
responses
components
two
vaccines
tetramune
trademark
expected
provide
protection
hib
well
diphtheria
tetanus
pertussis
equivalent
already
licensed
formulations
dtp
haemophilus
b
vaccines
advisory
committee
immunization
practices
acip
recommends
infants
receive
primary
series
one
licensed
haemophilus
b
conjugate
vaccines
beginning
months
age
booster
dose
age
months
acip
also
recommends
infants
receive
fourdose
primary
series
diphtheria
tetanus
toxoids
pertussis
vaccine
months
age
booster
dose
years
complete
statement
regarding
recommendations
use
acthib
trademark
tetramune
trademark
developed
reported
office
vaccines
research
review
center
biologics
evaluation
research
food
drug
administration
div
immunization
national
center
prevention
svcs
meningitis
special
pathogens
br
div
bacterial
mycotic
diseases
national
center
infectious
diseases
cdc
references
adams
wg
deaver
ka
cochi
sl
et
al
decline
childhood
haemophilus
influenzae
type
b
hib
disease
hib
vaccine
era
jama
broadhurst
le
erickson
rl
kelley
pw
decrease
invasive
haemophilus
influenzae
disease
us
army
children
jama
murphy
tv
white
ke
pastor
p
et
al
declining
incidence
haemophilus
influenzae
type
b
disease
since
introduction
vaccination
jama
hicnet
medical
newsletter
page
volume
number
april
fritzell
b
plotkin
efficacy
safety
haemophilus
influenzae
type
b
capsular
polysaccharidetetanus
protein
conjugate
vaccine
j
pediatr
acip
haemophilus
b
conjugate
vaccines
prevention
haemophilus
influenzae
type
b
disease
among
infants
children
two
months
age
older
recommendations
immunization
practices
advisory
committee
acip
mmwr
rr
acip
diphtheria
tetanus
pertussis
recommendations
vaccine
use
preventive
measures
recommendations
immunization
practices
advisory
committee
acip
mmwr
rr
acip
pertussis
vaccination
acellular
pertussis
vaccine
reinforcing
booster
use
supplementary
acip
statement
recommendations
immunization
practices
advisory
committee
acip
mmwr
rr
acip
pertussis
vaccination
acellular
pertussis
vaccine
fourth
fifth
doses
dtp
series
update
supplementary
acip
statement
recommendations
immunization
practices
advisory
committee
acip
mmwr
rr
use
trade
names
commercial
sources
identification
imply
endorsement
public
health
service
us
department
health
human
services
hicnet
medical
newsletter
page
volume
number
april
dental
news
international
workshop
explores
oral
manifestations
hiv
infection
nidr
research
digest
written
jody
dove
march
national
institute
dental
research
second
international
workshop
oral
manifestations
hiv
infection
held
january
february
san
francisco
participants
explored
issues
related
epidemiology
basic
molecular
virology
mucosal
immunology
oral
clinical
presentations
hiv
infection
workshop
organized
dr
john
greenspan
dr
deborah
greenspan
department
stomatology
school
dentistry
university
california
san
francisco
international
steering
committee
scientific
program
committee
provided
guidance
conference
drew
scientists
countries
including
asia
africa
europe
central
america
south
america
well
united
states
canada
support
tor
workshop
provided
national
institute
dental
research
national
cancer
institute
national
institute
allergy
infectious
diseases
nih
office
aids
research
procter
gamble
company
among
topics
discussed
epidemiology
hiv
lesions
ethics
professional
responsibility
public
policy
occupational
issues
provision
oral
care
hivpositive
population
salivary
hiv
transmission
mucosal
immunity
opportunistic
infections
pediatric
hiv
infection
womens
issues
recommendations
recommendations
emerged
workshop
define
association
appearance
oral
lesions
rate
progression
hiv
establish
universal
terminology
hivassociated
oral
lesions
look
effective
treatments
oral
manifestations
expand
molecular
biology
studies
understand
relationship
hiv
infection
common
oral
lesions
study
effects
hiv
therapy
oral
lesions
epidemiology
since
first
international
workshop
oral
manifestations
hiv
infection
convened
five
years
ago
epidemiology
hiv
infection
hicnet
medical
newsletter
page
volume
number
april
radically
changed
hiv
infection
detected
reported
largely
homosexual
bisexual
males
intravenous
drug
users
hemophiliacs
today
hiv
infection
seen
heterosexual
males
females
children
adolescents
predominant
impact
hiv
infection
felt
africa
major
increase
infection
rate
seen
southeast
asia
well
five
hundred
thousand
cases
reported
date
region
appearing
time
researchers
continuing
document
epidemiology
oral
lesions
hairy
leukoplakia
candidiasis
also
beginning
explore
relationships
specific
oral
lesions
hiv
disease
progression
prognosis
socialpolitical
issues
discussion
social
political
implications
hiv
infection
focused
changing
publics
attitude
aids
retribution
indiscriminate
sexual
behavior
drug
use
speakers
also
addressed
health
care
delivery
hivinfected
patients
need
educate
public
aids
acquired
saliva
salivary
glands
conference
speakers
described
transmission
issues
hivinhibitory
activity
saliva
strength
varies
among
different
salivary
secretions
whole
saliva
greater
inhibitory
effect
submandibular
secretions
turn
greater
inhibitory
effect
parotid
secretions
research
shown
least
two
mechanisms
responsible
salivary
inhibitory
activity
attributed
hivinhibitory
effect
saliva
aggregationagglutination
hiv
saliva
may
promote
clearance
virus
prevent
reaching
target
cell
direct
effects
virus
target
cells
topics
discussed
manifestation
salivary
gland
disease
hivinfected
persons
current
research
oral
mucosal
immunity
pediatric
issues
pediatric
aids
recently
emerged
area
intense
interest
early
accurate
diagnosis
proper
treatment
life
expectancy
hiv
infected
children
tripled
prevention
transmission
hiv
mother
child
may
possible
many
cases
particularly
mothers
serostatus
known
prior
giving
birth
periodontal
gingival
tissue
disease
hicnet
medical
newsletter
page
volume
number
april
oral
health
researchers
continue
explore
periodontal
diseases
gingivitis
found
individuals
hiv
infection
recommendations
made
workshop
include
standardization
terminology
refinement
diagnostic
markers
standardization
study
design
proper
consideration
confounding
variables
resulting
periodontal
therapy
occupational
treatment
issues
occupational
issues
surrounding
treatment
hivinfected
individuals
treatment
rendered
hivinfected
health
care
professionals
still
command
considerable
attention
factors
consideration
include
costbenefit
hiv
testing
patienttohealth
care
provider
transmission
hiv
infection
reverse
use
mainstream
versus
dedicated
facilities
treatment
hivinfected
patients
conference
participants
anticipate
third
international
workshop
oral
manifestations
hiv
infection
held
five
years
less
proceedings
second
workshop
published
quintessence
company
late
end
part
internet
fax
bitnet
fidonet
amateur
packet
ax
